MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL GALAXY G3 XSFT 2MM X 2CM; NEUROVASCULAR EMBOLIZATION DEVICE

Catalog Number	GLX120202
Medical Device Problem Code	Separation Failure (2547)
Health Effect - Clinical Code	No Clinical Signs, Symptoms or Conditions (4582)
Date of Event	12/01/2023
Type of Reportable Event	Malfunction
Additional Manufacturer Narrative
Product complaint # (b)(4).Information regarding patient weight, height, medical history, race, and ethnicity was not reported.Section d2b ¿ procode: krd/hcg section e1.Initial reporter phone: (b)(6).Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.The company is seeking this information through the event investigation.This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
Event or Problem Description
As reported by the field, during a coil embolization, an approached to the lesion was made and attempted to detached a galaxy g3 xsft 2mm x 2cm coil (glx120202, 30513176), but energization error occurred and replaced both the enpowercontrolcable and the galaxy g3 xsft coil with another new ones.After that, detachment could be done with no issues.The procedure was completed.There was no negative impact to the patient.A continuous flush was done.
Additional Manufacturer Narrative
Product complaint # (b)(4).Section b5: additional information was received on 14-dec-2023 indicating that a pre-deployment electrical testing was performed.The same dcb was used successfully with subsequent coils.The coil was still attached to the coil delivery system when removed from the patient.The coil did not stretch or damaged when removed.The procedure was delayed by several minutes and there was no impact on the procedure.The delay was not clinically significant.Complaint conclusion: as reported by the field, during a coil embolization, an approached to the lesion was made and attempted to detach a galaxy g3 xsft 2mm x 2cm coil (glx120202, 30513176), but energization error occurred and replaced both the enpowercontrolcable and the galaxy g3 xsft coil with another new ones.After that, detachment could be done with no issues.The procedure was completed.There was no negative impact to the patient.A continuous flush was done.Additional information was received on 14-dec-2023 indicating that a pre-deployment electrical testing was performed.The same dcb was used successfully with subsequent coils.The coil was still attached to the coil delivery system when removed from the patient.The coil did not stretch or damaged when removed.The procedure was delayed by several minutes and there was no impact on the procedure.The delay was not clinically significant.The device was discarded; therefore, no further investigation can be performed.A manufacturing record evaluation was performed for the finished device 30513167 number, and no non-conformances related to the malfunction were identified.With the information available and without the product available for analysis, the reported customer complaint could not be confirmed.Based on the manufacturing record evaluation, there is no indication that the event is related to the device manufacturing process.The exact cause of the event could not be determined; however, there are circumstances of the procedure that may have contributed to the reported failure.Failure to detach is a known potential issue associated with the use of this device.The instructions for use (ifu) contains several precautions related to this issue and includes instructions for troubleshooting the situation should it be encountered during use.As part of the post market surveillance program, information from this complaint is trended to identify statistical signals for consideration of further correction action.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.

• Brand Name: GALAXY G3 XSFT 2MM X 2CM
• Common Device Name: NEUROVASCULAR EMBOLIZATION DEVICE
• Manufacturer (Section D): MEDOS INTERNATIONAL SARL; chemin-blanc 38; le locle neuchatel CH-24 00; SZ CH-2400
• Manufacturer (Section G): CERENOVUS INC. (FREMONT); 47709 fremont blvd; fremont CA 94538
• Manufacturer Contact: kate karberg ; 31 technology dr; irvine, CA 92618 ; 3035526892
• MDR Report Key: 18319919
• Report Number: 3008114965-2023-00945
• Device Sequence Number: 7520186
• Product Code: KRD
• UDI-Device Identifier: 10886704077640
• UDI-Public: 10886704077640
• Combination Product (Y/N): N
• Initial Reporter Country: JA
• PMA/510(K) Number: K150319
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Serviced by Third Party (Y/N): Unknown
• Reporter Type: Manufacturer
• Report Source: Foreign,Health Professional
• Initial Reporter Occupation: Physician
• Type of Report: Initial,Followup
• Report Date (Section B): 12/18/2023

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 01/31/2024
• Device Catalogue Number: GLX120202
• Device Lot Number: 30513167
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 12/01/2023
• Supplement Date Received by Manufacturer: 12/14/2023
• Initial Report FDA Received Date: 12/13/2023
• Supplement Report FDA Received Date: 12/18/2023
• Was Device Evaluated by Manufacturer? (Y/N): Device Not Returned to Manufacturer
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: ENPOWER CONTROL CABLE; MARVEL MICROCATHETER
• Patient Sex: Unknown
• Patient Race: Asian